The decrease in Veradigm's stock price can be attributed to the market's initial reaction to the acquisition costs and the uncertainties surrounding the integration of ScienceIO. However, this strategic acquisition is aimed at enhancing Veradigm's data analytics capabilities, which could lead to long-term benefits.